美股医药股逆势上涨，阿斯利康涨超6%

Group 1 - The core viewpoint of the article highlights a notable increase in U.S. pharmaceutical stocks on October 1, with AstraZeneca rising over 6% [1] - Sanofi, Amgen, and GlaxoSmithKline saw nearly a 4% increase in their stock prices [1] - Eli Lilly, Boehringer Ingelheim, Novo Nordisk, and Merck experienced close to a 3% rise, while Pfizer's stock increased by over 2% [1]